Holen Sie sich die Stockscreener-App
120.91
2.84%
3.3368
Handel nachbörslich:
120.49
-0.4168
-0.34%
Schlusskurs vom Vortag:
$117.57
Offen:
$118.27
24-Stunden-Volumen:
11,561
Relative Volume:
0.47
Marktkapitalisierung:
$480.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+4.52%
1M Leistung:
+14.10%
6M Leistung:
+15.82%
1J Leistung:
+48.74%
1-Tages-Spanne:
$118.27
$120.91
1-Wochen-Bereich:
$116.10
$120.91
52-Wochen-Spanne:
$80.44
$120.91
Invesco Pharmaceuticals Etf Stock (PJP) Company Profile
Firmenname
Invesco Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare PJP vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PJP
Invesco Pharmaceuticals Etf
|
120.91 | 480.50M | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
368.76 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
744.78 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
748.43 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
300.34 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
712.60 | 124.43B | 0 | 0 | 0 | 0.00 |
Invesco Pharmaceuticals Etf Aktie (PJP) Neueste Nachrichten
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - Yahoo Finance
Invesco Pharmaceuticals ETF declares quarterly distribution of $0.2733 - MSN
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech - AOL.com
Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now? - Yahoo Finance
Technical Reactions to PJP Trends in Macro Strategies - Stock Traders Daily
Invesco's RSPH vs. PJP: Which Health Care ETF Is the Better Fund For The GLP-1 Revolution? - AOL.com
Is Invesco Leisure and Entertainment ETF (PEJ) a Strong ETF Right Now? - Yahoo Finance
PJP News | INVESCO PHARMACEUTICALS ETF (NYSEARCA:PJP) - ChartMill
Corcept Therapeutics Inc (CORT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Amphastar Pharmaceuticals Inc (AMPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Prestige Consumer Healthcare Inc (PBH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
United Therapeutics Corp (UTHR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Amylyx Pharmaceuticals Inc (AMLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ligand Pharmaceuticals Inc (LGND) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ocular Therapeutix Inc (OCUL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LENZ Therapeutics Inc (LENZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Merck & Co Inc (MRK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Jazz Pharmaceuticals PLC (JAZZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Avadel Pharmaceuticals PLC (AVDL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Amneal Pharmaceuticals Inc (AMRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Collegium Pharmaceutical Inc (COLL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Phathom Pharmaceuticals Inc (PHAT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Viatris Inc (VTRS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Harmony Biosciences Holdings Inc (HRMY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ANI Pharmaceuticals Inc (ANIP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Perrigo Company PLC (PRGO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tarsus Pharmaceuticals Inc (TARS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Innoviva Inc (INVA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biogen Inc (BIIB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Invesco RSPH and PJP: Evaluating Health Care ETFs Amid the GLP-1 Drug RevolutionEarnings Revision Downgrade - newsline.com
Abbott Laboratories (ABT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Supernus Pharmaceuticals Inc (SUPN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Harrow Inc (HROW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pfizer Inc (PFE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Esperion Therapeutics Inc (ESPR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Why 2 major Wall Street firms say healthcare stocks could be the market's next hot trade - Business Insider
Trading the Move, Not the Narrative: (PJP) Edition - Stock Traders Daily
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Yahoo Finance
Invesco Increases Optionality of its BulletShares Defined Maturity ETF Suite by adding Treasury Bond ETFs - PR Newswire
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Yahoo Finance
What Rising Real Estate Prices Are Telling Investors Right Now - MarketWise
Biotech ETFs: Which ETF Offers Lower Fees? IBBQ or XPH? - AOL.com
ETFs Investing in Jazz Pharmaceuticals Public Limited Company Stocks - TradingView
PJP vs XBI: Pharmaceutical vs Biotech ETF Comparison for InvestorsNews and Statistics - IndexBox
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio? - AOL.com
Invesco vs. SPDR Healthcare ETFs: Biotech and Pharma Fund ComparisonNews and Statistics - IndexBox
Finanzdaten der Invesco Pharmaceuticals Etf-Aktie (PJP)
Es liegen keine Finanzdaten für Invesco Pharmaceuticals Etf (PJP) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.82%
0.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):